HealthTech

Ro

Ro raises $500M Series D at $5B valuation

$500M

Total Raised

Series D

Latest Round

2017

Founded

800+

Employees

New York, NY

Updated March 18, 2021

1 min read

Quick Facts

Valuation

$5B

Latest Round Size

$500M

Latest Round Date

March 2021

Ro: Series D Funding Round

Ro has successfully raised $500M in Series D funding, reaching a valuation of $5B.

Company Overview

Direct-to-patient healthcare platform

Funding Details

The Series D round was led by General Catalyst, with participation from TCV.

Investment

Ro plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

General Catalyst: Verified investor in Series D
TCV: Verified investor in Series D

Key Investors

General Catalyst

Lead Investor

Verified investor in Series D

TCV

Investor

Verified investor in Series D

Topics

verified(1243)real-funding(1243)series-d(182)healthtech(156)new-york(105)ro(1)

About the Author

Editorial Team

Curated funding news from verified sources

Related Company Reports

HealthTech

AccelerateStack Platform

AccelerateStack Platform raises $75M Series C at $226M valuation

AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.

DermaSensor raises $16M Series B at $85M valuation

DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...

Devoted Health Partners

Devoted Health Partners Headquarters - Office Location & Address

Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.